title: [Economic perspectives of the research on advanced therapies].
abstract: Since a new advanced therapy medicinal product is discovered until finally allowed its sale in the domestic market, it has to overcome a series of stages. Biomedical research is the first phase, currently its situation is encouraging to the increase in the number of clinical trials in Spain and in the rest of the world, despite the economic situation and the various difficulties that have faced the pharmaceutical laboratories. The next phase consists in obtaining the authorization of marketing of the European Medicines Agency. After authorization, will attempt to set a fair and moderate price for inclusion in the list of health provision of Social Security. A price for a drug that provides added value to health and society, a price that is generated profits for the pharmaceutical companies that hope to make up for the years of work and investment. Commitment to advanced therapy must be clear and forceful, to fund ongoing research projects and encouraging their creation with economic aid.
authors.affiliation: Universidad de Salamanca. España.. txito@usal.es.
authors.forename: Jose María
authors.initials: JM
authors.lastname: Pamo Larrauri
mesh_terms: D016527:Drug Costs; D004358:Drug Therapy / Q000191:economics* / Q000639:trends; D005062:European Union; D006801:Humans; D009313:National Health Programs / Q000191:economics; D013030:Spain